Show simple item record

dc.contributor.authorLedesma Llorente, Juan Carlos
dc.contributor.authorEscrig Ayuso, Miguel Ángel
dc.contributor.authorPastor Medall, Raúl
dc.contributor.authorGonzález Aragón, Carlos Manuel
dc.description.abstractHydrogen peroxide is the co-substrate used by the enzyme catalase to form Compound I (the catalase–H2O2 system), which is the major pathway for the conversion of ethanol (EtOH) into acetaldehyde in the brain. This acetaldehyde has been involved in many of the effects of EtOH. Previous research demonstrated that treatments that change the levels of cerebral H2O2 available to catalase modulate the locomotor-stimulating effects of EtOH and its volitional intake in rodents. However, the source of H2O2 which is used by catalase to form Compound I and mediates the psychoactive actions of EtOH is unknown. One cause of the generation of H2O2 in the brain comes from the deamination of biogenic amines by the activity of MAO-A. Here we explore the consequences of the administration of the MAO-A inhibitor clorgyline on EtOH-induced locomotion and voluntary EtOH drinking. For the locomotor activity tests, we injected Swiss (RjOrl) mice intraperitoneally (IP) with clorgyline (0–10 mg/kg) and later (0.5–8 h) with EtOH (0–3.75 g/kg; IP). Following these treatments, mice were placed in locomotor activity chambers to measure their locomotion. For the drinking experiments, mice of the C57BL/6J strain were injected IP with clorgyline prior to offering them an EtOH (20%) solution following a drinking-in-the-dark procedure. Additional experiments were performed to assess the selectivity of this compound in altering EtOH-stimulated locomotion and EtOH intake. Moreover, we indirectly tested the ability of clorgyline to reduce brain H2O2 levels. We showed that this treatment selectively reduced EtOH-induced locomotion and its self-administration. Moreover, this compound decreased central H2O2 levels available to catalase. We suggest that H2O2 derived from the deamination of biogenic amines by the activity of MAO-A could determine the formation of brain EtOH-derived acetaldehyde. This centrally-formed acetaldehyde within the neurons of the aminergic system could play a role in the neurobehavioral properties of EtOH.ca_CA
dc.format.extent9 p.ca_CA
dc.relation.isPartOfPharmacology Biochemistry and Behavior, 2014, Volume 116ca_CA
dc.rights© 2013 Elsevier Inc. All rights reserved.ca_CA
dc.subjectLocomotor stimulationca_CA
dc.subjectEthanol intakeca_CA
dc.subjectMAO-A; H2O2ca_CA
dc.titleThe MAO-A inhibitor clorgyline reduces ethanol-induced locomotion and its volitional intake in miceca_CA

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record